Stifel analyst Rick Wise upgrades Silk Road Medical (NASDAQ:SILK) from Hold to Buy and raises the price target from $9 to $20.
Stifel Upgrades Silk Road Medical to Buy, Raises Price Target to $20
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.